Propylamphetamine
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Other names | N-propyl-1-phenyl-propan-2-amine; N-propylamphetamine |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.215.934 |
Chemical and physical data | |
Formula | C12H19N |
Molar mass | 177.291 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
NY (what is this?) |
Propylamphetamine is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes which acts as a stimulant. It was first developed in the 1970s, mainly for research into the metabolism of,[1] and as a comparison tool to, other amphetamines.[2] A study in rats found propylamphetamine to be 1/4 as potent as amphetamine.[3]
See also[]
- Amphetamine
- Ethylamphetamine
- Isopropylamphetamine
- Methamphetamine
- Phenylpropylaminopentane
References[]
- ^ Nazarali AJ, Baker GB, Coutts RT, Pasutto FM (1983). "Amphetamine in rat brain after intraperitoneal injection of N-alkylated analogues". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7 (4–6): 813–6. doi:10.1016/0278-5846(83)90073-8. PMID 6686713. S2CID 35531794.
- ^ Valtier S, Cody JT (October 1995). "Evaluation of internal standards for the analysis of amphetamine and methamphetamine". Journal of Analytical Toxicology. 19 (6): 375–80. doi:10.1093/jat/19.6.375. PMID 8926730.
- ^ Woolverton WL, Shybut G, Johanson CE (December 1980). "Structure-activity relationships among some d-N-alkylated amphetamines". Pharmacology, Biochemistry, and Behavior. 13 (6): 869–76. CiteSeerX 10.1.1.687.9187. doi:10.1016/0091-3057(80)90221-x. PMID 7208552. S2CID 25123820.
Stimulants | |
---|---|
Adamantanes |
|
Adenosine antagonists |
|
Alkylamines |
|
Ampakines | |
Arylcyclohexylamines |
|
Benzazepines |
|
Cathinones |
|
Cholinergics |
|
Convulsants |
|
Eugeroics |
|
Oxazolines |
|
Phenethylamines |
|
Phenylmorpholines |
|
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams |
|
Tropanes |
|
Tryptamines | |
Others |
|
ATC code: N06B |
Monoamine releasing agents | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRAs |
| ||||||||||||||
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Substituted amphetamines
- Norepinephrine-dopamine releasing agents
- Nervous system drug stubs
Hidden categories:
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes which contain changes to verified fields
- All stub articles